Dr Jonathan Kinlay is the chief executive of the investment research and consulting firm Investment Analytics and founder of the Proteom Fund, a quantitative stat arb. and volatility arbitrage hedge fund, whose algorithmic trading strategies are based on techniques from econometrics and the biosciences.
Dr. Kinlay was the founder and General Partner of the Caissa Capital volatility arbitrage fund, and was formerly Global Head of Model Review at Bear Stearns.
Dr Kinlay is on the finance faculty at NYU Stern where he lectures on hedge fund strategy. He studied for his PhD and other postgraduate degrees in Economics, Statistics and Business Administration from the Universities of Bristol, Sheffield, London and Cambridge.
No comments:
Post a Comment